A Phase 2, Multi-Center Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Mechanism of Action
ENV- 101, a potent Hedgehog (Hh) pathway inhibitor
Purpose
n/a
Location
Similar Trials
Yes
No
No
Connect With Us
Whether you want to give a spark of hope or you are looking for it, we are here to help. If you have any questions or concerns, please contact us here.